Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06682468 · ClinicalTrials.gov registry record · NA
Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life With HIV and Substance Use
A NA study of HIV and Substance Use Disorders, sponsored by University of Chicago.
- Active
- Registry status
- NA
- Development phase
- 900
- Enrollment target
- 1
- Study location
NCT06682468: Active NA study of HIV and Substance Use Disorders, sponsored by University of Chicago.
NCT06682468 is a NA study of HIV and Substance Use Disorders that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 900 participants, above the 437-participant average among 303 other HIV trials with a reported enrollment target (106% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06682468, a NA study of HIV and Substance Use Disorders, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to achieve health equity in substance use disorder (SUD) screening and treatment among people living with human immunodeficiency virus (HIV) by implementing interventions to decrease barriers to screening (clinic-based, in-person) and treatment (referral-focused), a program the study investigators call "Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life With HIV and Substance Use (ePORTAL HIV-S)." The ePORTAL HIV-S randomized control trial will focus on portal-based screening in the HIV clinic, regardless of whether the patient has a scheduled appointment with their HIV provider.
Primary Outcome
Percentage of participants who completed the validated NIDA Quick Screen V1.0 for substance use disorder in the HIV clinic.
Conditions Studied
Interventions
- BEHAVIORAL Population level patient portal based substance involvement screening
- BEHAVIORAL Usual Care Substance Use Involvement Screening
Study Locations (1)
Illinois
- University of Chicago Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2025-02-12 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT06682468 still lists
NCT06682468 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 437-participant average among 303 other HIV trials with a reported enrollment target (106% higher).
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Population level patient portal based substance involvement screening is the first listed.
NCT06682468 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06682468 about?
NCT06682468 is a clinical study titled "Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life With HIV and Substance Use". This study aims to achieve health equity in substance use disorder (SUD) screening and treatment among people living with human immunodeficiency virus (HIV) by implementing interventions to decrease barriers to screening (clinic-based, in-person) and treatment (referral-focused), a program the study...
What is the current status of trial NCT06682468?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2025-02-12. Estimated completion is 2026-12.
What conditions does trial NCT06682468 study?
This clinical trial studies the following conditions: HIV, Substance Use Disorders.
What interventions are being tested in trial NCT06682468?
The interventions under investigation include: Population level patient portal based substance involvement screening (BEHAVIORAL), Usual Care Substance Use Involvement Screening (BEHAVIORAL).
Who is sponsoring clinical trial NCT06682468?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06682468 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06682468's enrollment target sits among peer trials
900 21st of 303 higher than 282 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI